Publication date: May 2018
Source:European Journal of Cancer, Volume 95
Author(s): B. Fresneau, D. Orbach, C. Faure-Conter, H. Sudour-Bonnange, C. Vérité, V. Gandemer, M. Pasquet, S. Fasola, A. Rome, S. Raimbault, H. Martelli, D. Frappaz, G. Le Teuff, C. Patte
PurposeIn adults' non-seminomatous germ cell tumours (NS-GCT), alpha-fetoprotein (AFP) decline was identified as an important prognostic factor. We investigated its prognostic value in the French TGM95 study for childhood NS-GCT.Patients and methodsThree risk groups were defined: low risk (LR: localised and completely resected pS1, AFP<15000 ng/ml), with a 'wait-and-see' strategy; intermediate-risk (IR: localised incompletely resected, AFP<15000 ng/ml) with 3–5 vinblastine-bleomycine-cisplatin courses; high risk (HiR: AFP≥15000 ng/ml and/or metastatic) with 4–6 etoposide-ifosfamide-cisplatin courses. The multivariable prognostic analysis for progression-free survival (PFS) included age (±10 years), primary tumour site (1-testis, 2-ovary, 3-extragonadal), extent of disease (1-pS1, 2-loco-regional dissemination, 3-metastasis) and AFP (±10,000 ng/ml). AFP decline prognostic value was investigated in IR + HiR groups using predicted time to normalisation (TTN), AFP change, and difference between observed and expected (based on AFP half-life) area under the curve (O-E AUC).ResultsFrom January 1995 to December 2005, 239 patients (median age = 3years, 60 LR, 65 IR, 114 HiR) were included. Main sites were testis (n = 66), ovary (n = 77) and sacrococcygeal (n = 57). Five-year PFS and OS were 85% (95% confidence interval [CI] = 80–89%) and 93% (89–95%), respectively. Age ≥ 10 years (hazard ratio [HR] = 4.6, 95% CI = 2.1–10.1, p = 0.0001) and extragonadal primary (HR = 6.3, 95% CI = 2.0–19.9, p = 0.005) were significant prognostic factors. In AFP decline analysis (n = 151, 17 events), TTN (p = 0.61) and AFP change (p = 0.10) were not prognostic, whereas we showed a significant effect of O-E AUC (HR = 2.1, 95% CI = 1.0–4.2, p = 0.05).ConclusionAge ≥ 10 years and extragonadal tumours remain as poor prognostic factors. Contrary to adults, TTN is not reliable in paediatric NS-GCT. The prognostic value of O-E AUC should be investigated in larger studies.
from Cancer via ola Kala on Inoreader https://ift.tt/2I9aGqy
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου